Amryt Pharma plc (AMYT) Financial Statements
Amryt Pharma plc (AMYT) files with the U.S. Securities and Exchange Commission under CIK 0001783010. 10KGenie shows its annual statements from SEC filings.
Key Figures, Fiscal Year 2021
- Revenue
- $222.54 million
- Net Income
- $1.00 million
- Total Assets
- $816.06 million
- Net Cash from Operations
- $15.54 million
Fiscal year ended Dec 31, 2021. Latest periodic SEC filing: Apr 29, 2022. Source: SEC filings (EDGAR XBRL).
Open the full financial statements for AMYT in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History